|
CANTATA EvaluatorSM for AVNR |
|||||||
|---|---|---|---|---|---|---|---|
|
© 2024 BreakoutWatch.com |
New CE:
|
||||||
| Company Information | |||||||
| Symbol: | AVNR | ||||||
| Company: | Avanir Pharmaceuticals, Inc. | ||||||
| Company Description: | AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare, is the only over-the-counter treatment for cold sores that has been approved by the United Sates Food and Drug Administration (FDA). In October 2010, FDA approved NUEDEXTA, is a combination of dextromethorphan/quinidine, for the treatment of pseudobulbar affect (PBA). | ||||||
| Stock is Optionable: | No | ||||||
| SEC Filings | Edgar Online | ||||||
| General Due Diligence and Earnings Date Info: | Due Diligence | ||||||
| Exchange: | NASDAQ | ||||||
| CANTATA Evaluation for 11/21/2024 | |||||||
| CE Zone |
Time- liness | CET | CEF | CE* | Industry | Industry Rank |
Industry Score |
| - | 0/2 | / 7 | 0 / 11 | 0 /18 | / 215 | / 100 | |
*Excluding Timeliness
points |
|||||||
| Timeliness | |||||||
| Item | Data | Points | Maximum Possible |
||||
| 1 | Currently listed on CwH,
DB, HTF or SQZ watchlists
|
0 | 1 | ||||
| 2 | Broke out in last 5 days
and within 5% of BoP |
0 | 1 | ||||
Total Timeliness Points |
0 | 2 | |||||
| CANTATA Evaluation Technical (CET) | |||||||||||||
| Item | Data | Points | Maximum Possible |
||||||||||
| 1 | Price relative to 50 and 200 day moving averages; 50 day relative to 200 day moving average
|
0.00 | 3 | ||||||||||
| 2 | Relative Strength Rank
|
0.00 | 3 | ||||||||||
| 3 | Rank in Industry
|
0.00 | 1 | ||||||||||
| 4 | Price relative to 52 week high
|
0.00 | 1 | ||||||||||
| 5 | Up/Down Ratio
|
0.00 | 1 | ||||||||||
Miscellaneous Technical Data (no points assigned)
|
n/a | n/a | |||||||||||
| Total Technical Points (CET) | 0.00 | 9 | |||||||||||
| CANTATA Evaluation Fundamentals (CEF) | |||||||
| We do not have any fundamental data in our database for AVNR | |||||||
| Total Fundamental Points (CEF) | 0.00 | 11 | |||||
| Total CANTATA Evaluation Points | 0.00 | 20 | |||||